147 related articles for article (PubMed ID: 15716550)
21. Clinical use of 4-aminopyridine in patients with downbeat nystagmus.
Domínguez-Durán E; Mármol-Szombathy I; Baños-Roldán Ú; Sánchez-Gómez S
Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(1):40-44. PubMed ID: 31078225
[TBL] [Abstract][Full Text] [Related]
22. Medical treatment of acquired nystagmus.
Ehrhardt D; Eggenberger E
Curr Opin Ophthalmol; 2012 Nov; 23(6):510-6. PubMed ID: 23014266
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
Hess E
Neurology; 2011 Nov; 77(22):1996-7; author reply 1997. PubMed ID: 22123782
[No Abstract] [Full Text] [Related]
24. [Pharmacological treatment of nystagmus].
Pieh-Beisse C; Lagrèze WA
Ophthalmologe; 2011 Feb; 108(2):178-82. PubMed ID: 21253746
[TBL] [Abstract][Full Text] [Related]
25. The mixed blessing of treating symptoms in acute vestibular failure--evidence from a 4-aminopyridine experiment.
Beck R; Günther L; Xiong G; Potschka H; Böning G; Bartenstein P; Brandt T; Jahn K; Dieterich M; Strupp M; la Fougère C; Zwergal A
Exp Neurol; 2014 Nov; 261():638-45. PubMed ID: 25157903
[TBL] [Abstract][Full Text] [Related]
26. A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Claassen J; Spiegel R; Kalla R; Faldon M; Kennard C; Danchaivijitr C; Bardins S; Rettinger N; Schneider E; Brandt T; Jahn K; Teufel J; Strupp M; Bronstein A
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1392-9. PubMed ID: 23813743
[TBL] [Abstract][Full Text] [Related]
27. Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
Claassen J; Teufel J; Kalla R; Spiegel R; Strupp M
J Neurol; 2013 Feb; 260(2):668-9. PubMed ID: 23183922
[No Abstract] [Full Text] [Related]
28. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M
Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380
[TBL] [Abstract][Full Text] [Related]
29. Dalfampridine in patients with downbeat nystagmus--an observational study.
Claassen J; Feil K; Bardins S; Teufel J; Spiegel R; Kalla R; Schneider E; Jahn K; Schniepp R; Strupp M
J Neurol; 2013 Aug; 260(8):1992-6. PubMed ID: 23589193
[TBL] [Abstract][Full Text] [Related]
30. 18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.
Bense S; Best C; Buchholz HG; Wiener V; Schreckenberger M; Bartenstein P; Dieterich M
Neuroreport; 2006 Apr; 17(6):599-603. PubMed ID: 16603919
[TBL] [Abstract][Full Text] [Related]
31. Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine.
Feil K; Claaßen J; Bardins S; Teufel J; Habs M; Kalla R; Strupp M
J Neurol; 2013 May; 260(5):1426-8. PubMed ID: 23595790
[No Abstract] [Full Text] [Related]
32. Does 4-aminopyridine "beat" downbeat nystagmus?
Shaikh AG
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1298-9. PubMed ID: 23833267
[No Abstract] [Full Text] [Related]
33. 4-Aminopyridine ameliorates relapsing remitting experimental autoimmune encephalomyelitis in SJL/J mice.
Moriguchi K; Miyamoto K; Fukumoto Y; Kusunoki S
J Neuroimmunol; 2018 Oct; 323():131-135. PubMed ID: 30139717
[TBL] [Abstract][Full Text] [Related]
34. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.
Alviña K; Khodakhah K
J Neurosci; 2010 May; 30(21):7258-68. PubMed ID: 20505092
[TBL] [Abstract][Full Text] [Related]
35. Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report.
Löhle M; Schrempf W; Wolz M; Reichmann H; Storch A
Mov Disord; 2008 Jul; 23(9):1314-6. PubMed ID: 18442126
[TBL] [Abstract][Full Text] [Related]
36. Dalfampridine (Ampyra) for MS.
Med Lett Drugs Ther; 2010 Sep; 52(1347):73-4. PubMed ID: 20847716
[No Abstract] [Full Text] [Related]
37. Combination of BK channel opener and Kv4 channel inhibitor for treatment of cerebellar ataxia in mutant med mice.
Abbasi S; Abbasi A; Sarbaz Y
J Neuropsychiatry Clin Neurosci; 2013; 25(4):E41. PubMed ID: 24247886
[No Abstract] [Full Text] [Related]
38. Aminopyridine treatment in a patient with bilateral vestibular failure and cryptogenic downbeat nystagmus.
Spiegel R; Kalla R; Classen J; Bardins S; Anciães da Silva F; Farahmand P; Hahn A; Schneider E; Rettinger N; Jahn K; Brandt T; Strupp M
J Neuroophthalmol; 2012 Jun; 32(2):190. PubMed ID: 22487785
[No Abstract] [Full Text] [Related]
39. Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
Haghdoost-Yazdi H; Piri H; Faraji A; Fraidouni N; Dargahi T; Mahmudi M; Alipour Heidari M
Neurol Res; 2016 Apr; 38(4):294-300. PubMed ID: 27098232
[TBL] [Abstract][Full Text] [Related]
40. Upbeat nystagmus changes to downbeat nystagmus with upward gaze in a patient with Wernicke's encephalopathy.
Shin BS; Oh SY; Kim JS; Lee H; Kim EJ; Hwang SB
J Neurol Sci; 2010 Nov; 298(1-2):145-7. PubMed ID: 20832081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
